Benitec Biopharma, Inc. (BNTC)
8.65
-0.17
(-1.93%)
USD |
NASDAQ |
Oct 23, 16:00
8.64
-0.01
(-0.12%)
After-Hours: 20:00
Benitec Biopharma Price to Book Value : 1.682 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.682 |
| October 22, 2026 | 1.715 |
| October 21, 2026 | 1.653 |
| October 20, 2026 | 1.758 |
| October 19, 2026 | 1.625 |
| October 16, 2026 | 1.577 |
| October 15, 2026 | 1.645 |
| October 14, 2026 | 1.612 |
| October 13, 2026 | 1.678 |
| October 12, 2026 | 1.764 |
| October 09, 2026 | 1.725 |
| October 08, 2026 | 1.701 |
| October 07, 2026 | 1.748 |
| October 06, 2026 | 1.750 |
| October 05, 2026 | 1.795 |
| October 02, 2026 | 1.746 |
| October 01, 2026 | 1.863 |
| September 30, 2026 | 1.944 |
| September 29, 2026 | 1.896 |
| September 28, 2026 | 1.948 |
| September 25, 2026 | 1.865 |
| September 24, 2026 | 1.874 |
| September 23, 2026 | 1.911 |
| September 22, 2026 | 2.129 |
| September 21, 2026 | 2.115 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.143 |
| September 17, 2026 | 2.209 |
| September 16, 2026 | 2.146 |
| September 15, 2026 | 2.148 |
| September 14, 2026 | 2.349 |
| September 11, 2026 | 2.370 |
| September 10, 2026 | 2.376 |
| September 09, 2026 | 2.421 |
| September 08, 2026 | 2.474 |
| September 04, 2026 | 2.465 |
| September 03, 2026 | 2.419 |
| September 02, 2026 | 2.504 |
| September 01, 2026 | 2.393 |
| August 31, 2026 | 2.366 |
| August 28, 2026 | 2.425 |
| August 27, 2026 | 2.463 |
| August 26, 2026 | 2.504 |
| August 25, 2026 | 2.532 |
| August 24, 2026 | 2.471 |
| August 21, 2026 | 2.621 |
| August 20, 2026 | 2.530 |
| August 19, 2026 | 2.602 |
| August 18, 2026 | 2.504 |
| August 17, 2026 | 2.541 |
| August 14, 2026 | 2.442 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| Price | 8.65 |
| Earnings Yield | -12.57% |
| Market Cap | 297.71M |